Novartis to Cut Up to 130 Jobs at Basel Facility in Restructuring Move

Swiss pharmaceutical giant Novartis announced plans to reduce its workforce by up to 130 employees at its Basel location as part of an ongoing corporate restructuring. The job cuts reflect broader industry adjustments aimed at optimizing operational efficiency.

2 Sept, 14:29 — 2 Sept, 14:29

Post Share

Sources

Showing 1 of 2 sources

swissinfoHigh1d ago

Novartis to cut up to 130 jobs in Basel

The pharmaceutical company Novartis is cutting up to 130 jobs in Basel by the end of 2027. The reason, the company announced on Wednesday, is that it is discontinuing the small-scale production of biologics in the Kleinbasel district. In the future, other biologics sites around the world will take over the tasks of the Basel plant. The reason for discontinuing production is that individual lease agreements at the Kleinbasel site are coming to an end. Consequently, further operations will be r...

By swissinfo.ch

Read full article →

Coverage Timeline

First report: 20-minuten · 2 Sept, 13:36|Full coverage: 2 · 53m|Window: 53m

Left-leaningCenterRight-leaning

20-minuten2 Sept, 13:36First to report

Pharma-Riese streicht am Standort Basel bis zu 130 Stellen

swissinfo2 Sept, 14:29Latest update

Novartis to Cut Up to 130 Jobs at Basel Facility in Restructuring Move

Sources

Novartis to cut up to 130 jobs in Basel

Coverage Timeline

Pharma-Riese streicht am Standort Basel bis zu 130 Stellen

Novartis to cut up to 130 jobs in Basel

Related Stories

Trump Demands European Repayment for Ukraine Military Aid

U.S. Trade Deficit Widens to $88.6 Billion in July

Global Markets Rally as Investors Ease Rate Hike Expectations Ahead of Fed Signals

Japanese Yen Strengthens Against Dollar on BOJ Rate Hike Expectations